In combination, these drugs promote satiety via enhancement of hypothalamic pro-opiomelanocortin (POMC) cell-mediated release of melanocyte-stimulating hormone (MSH) leading to reduced food intake and increased energy expenditure [16]
Understanding your baseline health profile and genetic predispositions supports a more informed, precision-focused conversation with your provider about whether GLP-1 and berberine is appropriate for your specific situation
With the successive launch of Glucagon-like peptide-1 (GLP-1) class drugs that allow weight loss with a once-daily pill instead of an injection, the barrier to obesity treatment is lowering
Food Standards Australia New Zealand
Several studies have investigated the potential therapeutic implications of reducing homocysteine levels in diabetic retinopathy
Benefits Increased energy levels and reduced fatigue Enhanced metabolism, assisting with weight management Improved mood and reduction in symptoms of depression Boosted cognitive function, including memory and concentration Strengthened immune system Healthier skin, hair, and nails Decreased risk of heart disease by lowering homocysteine levels Improved sleep patterns Increased red blood cell production, preventing anemia Enhanced nerve health and neurological function FAQ's Who is a good candidate
